At the sixth annual BIO Patient and Health Advocacy Summit in Washington, D.C. this week, a discussion on clinical trial design explored some of the challenges of ensuring patient's needs are balanced with those of drug developers and regulatory needs.
After a decade at the helm, Organovo's Keith Murphy is stepping down, to be replaced by eStudySite's Taylor Crouch. It marks a new era of commercialization for the San Diego company that has long been a pioneer in the 3D bioprinting of tissues and organs.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
BioBots, a Philadelphia startup that develops 3D bioprinters, will debut its new $10,000, desktop machine that will help scientists print out their own tissues for preclinical research.
Biobots, Freenome, LignaMed, Telesis and OriMAbs - all life sciences startups - have taken residence in Philadelphia's University Science Center accelerator. Their focuses range from cancer diagnostics to 3D bioprinting.